Publisher
Springer Berlin Heidelberg
Reference7 articles.
1. Hutson TE, Figlin RA, Kuhn JG, Motzer RJ (2008) Targeted therapies for metastatic renal cell carcinoma: an overview of toxicity and dosing strategies. Oncologist 13:1084–1096
2. Kovacs G (1993) Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62:89–124
3. Larkin JMG, Chowdhury S, Gore ME (2007) Drug insight: advances in renal cell carcinoma and the role of targeted therapies. Nat Clin Pract Oncol 4:470–479
4. Linehan WM, Yang JC, Bates SE (2004) Cancer of the kidney. In: DeVita SE, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology, 7th edn. Lippincott Williams & Wilkins, Philadelphia
5. Lubensky IA, Schmidt L, Zhuang Z et al (1999) Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. Am J Pathol 155:517–516